Renal Artery Stent Outcomes: Effect of Blood Pressure, Stenosis Severity, and Translesion Pressure Gradient.

Timothy P. Murphy
Christopher J. Cooper
Alan H. Matsumoto
Donald E. Cutlip
Karol M. Pencina
Kenneth Jamerson
Katherine R. Tuttle
Joseph I. Shapiro MD, Marshall University
Ralph D'Agostino
Joseph Massaro
William Henrich
Lance D. Dworkin

Copyright © 2018 by the American College of Cardiology Foundation. All rights reserved.


Background: Multiple randomized clinical trials comparing renal artery stent placement plus medical therapy with medical therapy alone have not shown any benefit of stent placement. However, debate continues whether patients with extreme pressure gradients, stenosis severity, or baseline blood pressure benefit from stent revascularization.

Objectives: The study sought to test the hypothesis that pressure gradients, stenosis severity, and/or baseline blood pressure affects outcomes after renal artery stent placement.

Methods: Using data from 947 patients with a history of hypertension or chronic kidney disease from the largest randomized trial of renal artery stent placement, the CORAL (Cardiovascular Outcomes in Renal Atherosclerotic Lesions) study, we performed exploratory analyses to determine if subsets of patients experienced better outcomes after stent placement than the overall cohort. We examined baseline stenosis severity, systolic blood pressure, and translesion pressure gradient (peak systolic and mean) and performed interaction tests and Cox proportional hazards analyses for the occurrence of the primary endpoint through all follow-up, to examine the effect of these variables on outcomes by treatment group.

Results: There were no statistically significant differences in outcomes based on the examined variables nor were there any consistent nonsignificant trends.

Conclusions: Based on data from the CORAL randomized trial, there is no evidence of a significant treatment effect of the renal artery stent procedure compared with medical therapy alone based on stenosis severity, level of systolic blood pressure elevation, or according to the magnitude of the trans-stenotic pressure gradient. (Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions [CORAL]; NCT00081731)